Toxoplasmosis-associated deaths among human immunodeficiency virus-infected persons in the United States, 1992-1998 [4]

Clinical Infectious Diseases

Volumn 34, Issue 8, 2002, Pages 1161-

  Jones, Jeffrey L ^a   Sehgal, Meena ^a   Maguire, James H ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT;

CAUSE OF DEATH; DRUG EFFICACY; ENCEPHALITIS; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LETTER; MAJOR CLINICAL STUDY; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR; TOXOPLASMOSIS; TREATMENT OUTCOME; UNITED STATES;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; TOXOPLASMOSIS; UNITED STATES;

EID: 0037090136     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/339752     Document Type: Letter

References (2)

1. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era